Matches in Wikidata for { <http://www.wikidata.org/entity/Q57313076> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q57313076 description "article scientifique publié en 2009" @default.
- Q57313076 description "article" @default.
- Q57313076 description "im September 2009 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57313076 description "wetenschappelijk artikel" @default.
- Q57313076 description "наукова стаття, опублікована у вересні 2009" @default.
- Q57313076 name "Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-" @default.
- Q57313076 name "Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events" @default.
- Q57313076 type Item @default.
- Q57313076 label "Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-" @default.
- Q57313076 label "Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events" @default.
- Q57313076 prefLabel "Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-" @default.
- Q57313076 prefLabel "Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events" @default.
- Q57313076 P1433 Q57313076-5C3F6596-C3AA-4169-ACF1-21C89A9015CE @default.
- Q57313076 P1476 Q57313076-AA1EC38C-9C0A-4E8B-938A-D578D9541D97 @default.
- Q57313076 P2093 Q57313076-0EBDA245-1A14-4374-B34E-7F8F13C14459 @default.
- Q57313076 P2093 Q57313076-36F9F67E-BD14-405C-A453-17F5B27FFF21 @default.
- Q57313076 P2093 Q57313076-7DC8B368-025D-459E-86CA-DC0A9402753A @default.
- Q57313076 P2093 Q57313076-877935AF-F4B3-4B5C-9219-F86EE7B46361 @default.
- Q57313076 P2093 Q57313076-A984C2F6-8F70-44BF-9D05-4496618DC512 @default.
- Q57313076 P2093 Q57313076-B3D2F5A2-A363-4918-B099-780B8B678A20 @default.
- Q57313076 P2093 Q57313076-D5E21C8E-7FD9-4459-83D5-6E6C1814B850 @default.
- Q57313076 P2093 Q57313076-FB57E89A-A7C0-4C49-B3A0-CFFD21C08BC5 @default.
- Q57313076 P304 Q57313076-71FA4314-5AF1-4BCF-8D9A-63D622F1A780 @default.
- Q57313076 P31 Q57313076-610A7BE9-3EED-4B85-A2FF-0C71A6C02107 @default.
- Q57313076 P356 Q57313076-F840CEA9-BF70-4C5D-BD21-3247EA276005 @default.
- Q57313076 P407 Q57313076-8E52A6EA-D86F-4303-ABE7-4486E1082180 @default.
- Q57313076 P433 Q57313076-D81EF910-2C4C-4C3C-8B3F-74577E5E43F0 @default.
- Q57313076 P478 Q57313076-579230CC-0CB5-4ED4-90DD-C6581DF4C721 @default.
- Q57313076 P50 Q57313076-0A1AF44A-E73B-4990-B1C9-8667D14780B4 @default.
- Q57313076 P50 Q57313076-EE52C8E1-54DD-4B12-BADA-DBE3B21D7618 @default.
- Q57313076 P577 Q57313076-E12E6415-1301-429E-8DA1-44157DB27060 @default.
- Q57313076 P698 Q57313076-0BC8AD01-11EE-4D07-8A7F-2F7909393C04 @default.
- Q57313076 P921 Q57313076-8A256F36-74B4-4290-BE39-446E04CDA991 @default.
- Q57313076 P921 Q57313076-D9DD65D8-DE8C-4278-89EE-BF6E63F319BA @default.
- Q57313076 P356 J.AHJ.2009.06.027 @default.
- Q57313076 P698 19699854 @default.
- Q57313076 P1433 Q2227156 @default.
- Q57313076 P1476 "Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-" @default.
- Q57313076 P2093 "Benjamin M. Scirica" @default.
- Q57313076 P2093 "Carolyn H. McCabe" @default.
- Q57313076 P2093 "David A. Morrow" @default.
- Q57313076 P2093 "Gail Berman" @default.
- Q57313076 P2093 "John Strony" @default.
- Q57313076 P2093 "Keith A.A. Fox" @default.
- Q57313076 P2093 "Marc P. Bonaca" @default.
- Q57313076 P2093 "Polly Fish" @default.
- Q57313076 P304 "335-341.e3" @default.
- Q57313076 P31 Q13442814 @default.
- Q57313076 P356 "10.1016/J.AHJ.2009.06.027" @default.
- Q57313076 P407 Q1860 @default.
- Q57313076 P433 "3" @default.
- Q57313076 P478 "158" @default.
- Q57313076 P50 Q114427079 @default.
- Q57313076 P50 Q322114 @default.
- Q57313076 P577 "2009-09-01T00:00:00Z" @default.
- Q57313076 P698 "19699854" @default.
- Q57313076 P921 Q12252367 @default.
- Q57313076 P921 Q181600 @default.